Skip to content

Effect of L-carnitine in carpal tunnel syndrome

Comparison of effectiveness of L-carnitine with placebo in improving symptoms, electrodiagnostic study and sonographic parameters in patient with carpal tunnel syndrome

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20200307046711N1
Enrollment
30
Registered
2020-04-01
Start date
2019-05-15
Completion date
Unknown
Last updated
2020-04-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Carpal tunnel syndrome. Carpal tunnel syndrome

Interventions

Intervention 1: Intervention group: received L-carnitine? coren company, 500 mg twice per day for 6 weeks, combination of metionin and lysine amino acid,. Intervention 2: Intervention group: received

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Parsons who there CTS is confirmed by electrodiagnostic study and clinical signe and symptoms Patients who aged 18 to 65 years old

Exclusion criteria

Exclusion criteria: Diseases such as diabetes mellitus, hypothyroidism, rheumatologic diseases, end stage renal disease Patients who use chemotherapy drugs or any drug that cause neuropathy Pregnant or breast feeding women History of seizure Bon mass index > 40 or <18 History of drug allergy Uncontrolled blood pressure

Design outcomes

Primary

MeasureTime frame
Electrodiagnostic parameters. Timepoint: Before intervention, 4 then 6 weeks after onset. Method of measurement: Electrodiagnostic instruments.;Hand pain and function. Timepoint: before intervention, 4 then 6 weeks after onset. Method of measurement: Boston questioner.;Cross sectional area of median nerve at wrist. Timepoint: Before intervention, 4 then 6 weeks after onset. Method of measurement: Sonography instrument.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactNarges Nikpay

Shiraz University of Medical Sciences

N_Nilpay@sums.ac.ir+98 71 3231 9040

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026